Suzana David

Dr. Suzana David


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2000 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
MVMiguel Viveiros
Miguel Viveiros
SDSuzana David
Suzana David
LALeonard Amaral
Leonard Amaral

1 September 2000 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
SDSuzana David
Suzana David
VBVanessa Barros
Vanessa Barros
Sandra Cabo VerdeSandra Cabo Verde
Sandra Cabo Verde
CPClara Portugal
Clara Portugal
HDHugo L. David
Hugo L. David
Subinhibitory concentrations of bacitracin, vancomycin and other inhibitors of cell wall synthesis reversed to varying extents the intrinsic resistance of Mycobacterium tuberculosis to clarithromycin. Ethambutol reversed clarithromycin resistance in all of the M. tuberculosis strains studied regardless of their susceptibility to this drug.

1 February 2001 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
SDSuzana David
Suzana David
D-Cycloserine (DCS) is a peptidoglycan inhibitor. Although very effective against Mycobacterium tuberculosis, it is seldom employed in the management of this infection due to its high toxicity. β-Chloro-d-alanine (another peptidoglycan inhibitor) reduces the MIC of DCS from 50 to 2.5 mg/L at a concentration significantly below its MIC for this organism. A reduction in bacterial viability and significant growth inhibition (as quantified by the X/Y quotient for the Bactec radiometric procedure) were observed with subinhibitory concentrations of both drugs. It is suggested that this powerful synergic effect should be the object of in vivo and eventually clinical trials.

1 October 2005 in FEMS Microbiology Letters
Verified
Journal Article
Closed access
SDSuzana David
Suzana David
VBVanessa Barros
Vanessa Barros
Carla CruzCarla Cruz
Carla Cruz
RDRita Delgado
Rita Delgado
In mycobacteria, the study of inhibition by metal ions has been limited by the absence of suitable molecular vectors. Recently, we reported on the inhibitory activity of a family of chelators, macrocyclic compounds (MCC), against Mycobacterium tuberculosis. In this study equimolar concentrations of the free cations vanadium(IV), arsenic(III), iron(III), indium(III) and bismuth(III), and as 1:1 complexes with the MCC 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetra-acetic acid (TETA) were tested in vitro against M. tuberculosis using the Bactec 460 TB radiometric technology (Becton-Dickinson, MD, USA). Radiometric inhibition above 80% was obtained with free indium(III) and bismuth(III), and ranged from 80% to 99%, with the complexes of TETA with vanadium(IV), bismuth(III) and indium(III), in the order of increasing activity. The highest radiometric inhibition levels were obtained with the [In(TETA)]- complex, which caused drops of up to 4 log units in cellular viability. The minimal inhibitory concentration of this compound was evaluated at 3 microM.

1 October 2012 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
SDSuzana David
Suzana David
EDElsa Leclerc Duarte
Elsa Leclerc Duarte
CLClarice Queico Fugimura Leite
Clarice Queico Fugimura Leite
JRJoão-Nuno Ribeiro
João-Nuno Ribeiro
JMJosé-Nuno Maio
José-Nuno Maio
JSJosé Germano de Sousa
José Germano de Sousa

1 September 2007 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
SDSuzana David
Suzana David
DRDiana Raposo Ribeiro
Diana Raposo Ribeiro
AAAbílio Antunes
Abílio Antunes
CPClara Portugal
Clara Portugal
LSLuísa Sancho
Luísa Sancho
JSJosé Germano de Sousa
José Germano de Sousa